查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1593929

疟疾疫苗市场：按类型、药物和最终用户划分 - 全球预测 2025-2030

Malaria Vaccine Market by Type (Erythrocytic Vaccine, Multi-Antigen Vaccine, Pre-Erythrocytic Vaccine), Agent (Anopheles Species, Plasmodium Falciparum, Plasmodium Vivax), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年疟疾疫苗市场规模预估为6,434万美元，预计2024年将达8,088万美元，复合年增长率为25.78%，预计2030年将达3,2066万美元。

疟疾疫苗市场的定义是其在疟疾控制中的关键作用，特别是在疟疾流行地区，主要是非洲、东南亚和拉丁美洲部分地区。疟疾导致显着的发病率和死亡率，并继续构成全球健康负担，这一事实凸显了对疟疾疫苗的需求。疟疾疫苗的主要用途是进行免疫，以降低感染率和传播，有助于改善受影响地区的公共卫生并提高经济生产力。主要最终用户包括政府卫生机构、非政府组织、公共卫生倡议和一定规模的私人医疗保健提供者。根据市场洞察，增加研发投资、生物技术进步以及全球健康伙伴关係关係等因素正在对市场成长产生正面影响。最近的进展包括世界卫生组织核准RTS,S/AS01 (Mosquirix) 疫苗，为扩大到大规模免疫规划提供了重大机会。为了有效利用这些机会，建议与国际卫生组织建立策略伙伴关係并投资低温运输基础设施。

主要市场统计
基准年[2023] 6434万美元
预测年份 [2024] 8088万美元
预测年份 [2030] 32066万美元
复合年增长率（%） 25.78%

限制和挑战包括疫苗分发的后勤障碍、偏远地区缺乏意识、潜在的副作用和疫苗储存问题，特别是在资源有限的环境中。此外，资金筹措的不确定性和对疫苗部分抗药性的疟疾菌株的出现对进一步增长构成了障碍。然而，创新机会比比皆是，特别是在开发具有更广泛毒株覆盖范围和更高功效的疫苗方面。探索具有成本效益的製造方法和多平台技术，使交付更容易，将推动业务成长。该市场在严格的监管框架的阴影下发展，仍然高度活跃，很大程度上是由对永续性和可及性的需求所驱动的。因此，企业必须优先考虑技术主导的解决方案，以提高低收入地区的物流和配送效率，并专注于确保可负担性的合作模式。

市场动态：揭示快速发展的疟疾疫苗市场的关键市场洞察

供需的动态交互作用正在改变疟疾疫苗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 常规免疫项目快速增加
    • 提高疟疾疫苗的可用性、可近性和政府的有利支持
    • 提高患者对疟疾的认识和发病率
  • 市场限制因素
    • 疫苗高成本
  • 市场机会
    • 新型佐剂和突破性疫苗输送计划的不断出现
    • 製药业在疫苗方面不断取得进展
  • 市场挑战
    • 严格监管场景

波特五力：驾驭疟疾疫苗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解疟疾疫苗市场的外部影响

外部宏观环境因素在塑造疟疾疫苗市场表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解疟疾疫苗市场的竞争格局

疟疾疫苗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们的公司能够应对日益激烈的竞争。

FPNV 定位矩阵疟疾疫苗市场供应商的绩效评估

FPNV 定位矩阵是评估疟疾疫苗市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製疟疾疫苗市场的成功之路

疟疾疫苗市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加常规免疫计划
      • 改善疟疾疫苗的供应、可近性和政府的有利支持
      • 提高患者对疟疾的认识和发病率
    • 抑制因素
      • 疫苗高成本
    • 机会
      • 新佐剂和创新疫苗管理方案的不断出现
      • 製药业在疫苗方面取得进展
    • 任务
      • 严格监管场景
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章疟疾疫苗市场：依类型

  • 红血球疫苗
  • 多重抗原疫苗
  • 前红血球疫苗

第七章 疟疾疫苗市场（依代理商）

  • 依蚊
  • 疟疾原虫
  • 疟疾原虫

第八章疟疾疫苗市场：依最终用户分类

  • 诊所
  • 社区中心
  • 医院

第九章美洲疟疾疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区疟疾疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲疟疾疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Amyris, Inc.
  • Bharat Biotech International Limited
  • Cadila Healthcare Ltd.
  • CellFree Sciences Co.,Ltd.
  • GenVec, Inc.
  • GlaxoSmithKline PLC
  • Ipca Laboratories Limited
  • Merck & Co., Inc
  • Mymetics Corporation
  • Novartis AG
  • Novavax, Inc.
  • Precigen, Inc.
  • Sanaria Inc.
  • Sumaya Biotech
  • Sun Pharmaceutical Industries Limited
Product Code: MRR-035DA3C63710

The Malaria Vaccine Market was valued at USD 64.34 million in 2023, expected to reach USD 80.88 million in 2024, and is projected to grow at a CAGR of 25.78%, to USD 320.66 million by 2030.

The malaria vaccine market is defined by its critical role in combating the malaria epidemic, particularly in malaria-endemic regions predominantly across Africa, Southeast Asia, and parts of Latin America. The necessity of a malaria vaccine is underscored by the persistent global health burden malaria poses, leading to significant morbidity and mortality. The primary application of malaria vaccines involves preventive inoculations to reduce infection rates and transmission, thus contributing to public health improvement and economic productivity in affected regions. Key end-users include government health bodies, non-governmental organizations, public health initiatives, and potentially private healthcare providers as distribution scales. Market insights indicate that factors such as increasing R&D investments, advancements in biotechnology, and global health partnerships are positively influencing market growth. Recent developments include WHO's approval of the RTS,S/AS01 (Mosquirix) vaccine, which presents significant opportunity for expansion into larger immunization programs. Leveraging strategic partnerships with international health agencies and investing in cold chain infrastructure are recommended to harness these opportunities effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 64.34 million
Estimated Year [2024] USD 80.88 million
Forecast Year [2030] USD 320.66 million
CAGR (%) 25.78%

Limitations and challenges include logistical hurdles in vaccine distribution, lack of awareness in remote areas, potential side effects, and vaccine storage issues, particularly in resource-limited settings. Moreover, funding uncertainties and the emergence of malaria strains with partial vaccine resistance pose additional growth barriers. However, opportunities for innovation abound, particularly in developing vaccines with broader strain coverage and improved efficacy. Research into cost-effective production methods and multi-platform technologies that facilitate easier delivery can drive business growth. The market, evolving under the shadow of stringent regulatory frameworks, remains highly dynamic and primarily driven by the need for sustainability and accessibility. Hence, companies must focus on collaborative models that ensure affordability and prioritize technology-driven solutions that enhance logistics and distribution efficiency in lower-income regions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Malaria Vaccine Market

The Malaria Vaccine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Proliferation in the number of routine immunizations programs
    • Rising availability, accessibility and favorable government support for malaria vaccine
    • Growing patient awareness and incidence of malaria
  • Market Restraints
    • High cost of the vaccines
  • Market Opportunities
    • Ongoing advent of novel adjuvants and breakthrough vaccine delivery programs
    • Rising advancements in pharmaceutical industry for vaccines
  • Market Challenges
    • Rigid regulative scenarios

Porter's Five Forces: A Strategic Tool for Navigating the Malaria Vaccine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Malaria Vaccine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Malaria Vaccine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Malaria Vaccine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Malaria Vaccine Market

A detailed market share analysis in the Malaria Vaccine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Malaria Vaccine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Malaria Vaccine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Malaria Vaccine Market

A strategic analysis of the Malaria Vaccine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Malaria Vaccine Market, highlighting leading vendors and their innovative profiles. These include Amyris, Inc., Bharat Biotech International Limited, Cadila Healthcare Ltd., CellFree Sciences Co.,Ltd., GenVec, Inc., GlaxoSmithKline PLC, Ipca Laboratories Limited, Merck & Co., Inc, Mymetics Corporation, Novartis AG, Novavax, Inc., Precigen, Inc., Sanaria Inc., Sumaya Biotech, and Sun Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Malaria Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Erythrocytic Vaccine, Multi-Antigen Vaccine, and Pre-Erythrocytic Vaccine.
  • Based on Agent, market is studied across Anopheles Species, Plasmodium Falciparum, and Plasmodium Vivax.
  • Based on End-User, market is studied across Clinics, Community Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Proliferation in the number of routine immunizations programs
      • 5.1.1.2. Rising availability, accessibility and favorable government support for malaria vaccine
      • 5.1.1.3. Growing patient awareness and incidence of malaria
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advent of novel adjuvants and breakthrough vaccine delivery programs
      • 5.1.3.2. Rising advancements in pharmaceutical industry for vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Rigid regulative scenarios
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Malaria Vaccine Market, by Type

  • 6.1. Introduction
  • 6.2. Erythrocytic Vaccine
  • 6.3. Multi-Antigen Vaccine
  • 6.4. Pre-Erythrocytic Vaccine

7. Malaria Vaccine Market, by Agent

  • 7.1. Introduction
  • 7.2. Anopheles Species
  • 7.3. Plasmodium Falciparum
  • 7.4. Plasmodium Vivax

8. Malaria Vaccine Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Community Centers
  • 8.4. Hospitals

9. Americas Malaria Vaccine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Malaria Vaccine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Malaria Vaccine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amyris, Inc.
  • 2. Bharat Biotech International Limited
  • 3. Cadila Healthcare Ltd.
  • 4. CellFree Sciences Co.,Ltd.
  • 5. GenVec, Inc.
  • 6. GlaxoSmithKline PLC
  • 7. Ipca Laboratories Limited
  • 8. Merck & Co., Inc
  • 9. Mymetics Corporation
  • 10. Novartis AG
  • 11. Novavax, Inc.
  • 12. Precigen, Inc.
  • 13. Sanaria Inc.
  • 14. Sumaya Biotech
  • 15. Sun Pharmaceutical Industries Limited

LIST OF FIGURES

  • FIGURE 1. MALARIA VACCINE MARKET RESEARCH PROCESS
  • FIGURE 2. MALARIA VACCINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MALARIA VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MALARIA VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MALARIA VACCINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MALARIA VACCINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MALARIA VACCINE MARKET SIZE, BY AGENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MALARIA VACCINE MARKET SIZE, BY AGENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MALARIA VACCINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MALARIA VACCINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MALARIA VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MALARIA VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MALARIA VACCINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MALARIA VACCINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MALARIA VACCINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MALARIA VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MALARIA VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MALARIA VACCINE MARKET DYNAMICS
  • TABLE 7. GLOBAL MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MALARIA VACCINE MARKET SIZE, BY ERYTHROCYTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MALARIA VACCINE MARKET SIZE, BY MULTI-ANTIGEN VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MALARIA VACCINE MARKET SIZE, BY PRE-ERYTHROCYTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MALARIA VACCINE MARKET SIZE, BY ANOPHELES SPECIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MALARIA VACCINE MARKET SIZE, BY PLASMODIUM FALCIPARUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MALARIA VACCINE MARKET SIZE, BY PLASMODIUM VIVAX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MALARIA VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MALARIA VACCINE MARKET SIZE, BY COMMUNITY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MALARIA VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES MALARIA VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. MALARIA VACCINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. MALARIA VACCINE MARKET, FPNV POSITIONING MATRIX, 2023